IP Verse

Methods And Materials For Assessing Loss Of Heterozygosity - EP2794907

The patent EP2794907 was granted to Abkevich on Nov 23, 2022. The application was originally filed on Dec 21, 2012 under application number EP12860530A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2794907

ABKEVICH
Application Number
EP12860530A
Filing Date
Dec 21, 2012
Status
Patent Maintained As Amended
Oct 21, 2022
Grant Date
Nov 23, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

NEO NEW ONCOLOGYAug 13, 2020ADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONWO2004075833
INTERNATIONAL-SEARCH-REPORTUS2010159466
INTERNATIONAL-SEARCH-REPORTWO2011160063
OPPOSITIONWO2009148528
OPPOSITIONWO2011160063
SEARCHWO2011160063

Non-Patent Literature (NPL) Citations (35) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- TELLI MELINDA L ET AL, "Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.", JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY 10 JUN 2015, (20150610), vol. 33, no. 17, ISSN 1527-7755, pages 1895 - 1901-
EXAMINATION- Victor Abkevich ET AL, "Supplementary Material for: Patterns of Genomic Loss of Heterozygosity Predict Homologous Recombination Repair Defects in Epithelial Ovarian Cancer", (20120101), URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493866/bin/bjc2012451x10.doc, (20170717), XP055391506-
EXAMINATION- V Abkevich ET AL, "Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer", British Journal of Cancer, (20121106), vol. 107, no. 10, doi:10.1038/bjc.2012.451, ISSN 0007-0920, pages 1776 - 1782, XP055085758
OPPOSITION- (20200805), URL: https://www.medverqleich.de/krankheiten/eierstockkrebs.html-
OPPOSITION- (20200805), URL: https://www.medverqleich.de/krankheiten/eierstockkrebs.html, XP055821607-
OPPOSITION- Abkevich et al., British Journal of Cancer (2012) 107: 1776-1782-
OPPOSITION- Anonymous, "Definition of primary cancer", NIH National Cancer Institute, (20200730), pages 1 - 1, NIH National Cancer Institute, URL: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/primary-cancer, (20210706), XP055821633-
OPPOSITION- Anonymous, "GeneChip@ Human Mapping 100K Set", Affymetrix Data Sheet, (20050101), pages 1 - 4-
OPPOSITION- Anonymous, "GeneChip@ Human Mapping 100K Set", Affymetrix Data Sheet, (20050101), pages 1 - 4, XP055821637-
OPPOSITION- Anonym, "Primärtumor", DocCheck Flexikon, (20150518), pages 1 - 1, DocCheck Flexikon, URL: https://flexikon.doccheck.com/de/Primartumor, (20210706), XP055821614-
OPPOSITION- De Waal Y, Et Al, "Secondary Ovarian Malignancies: Frequency, Origin, and Characteristics", Gynecological Cancer, (20090101), vol. 19, no. 7, pages 1 - 4-
OPPOSITION- De Waal Y, Et Al, "Secondary Ovarian Malignancies: Frequency, Origin, and Characteristics", Gynecological Cancer, (20090101), vol. 19, no. 7, pages 1 - 4, XP055821597-
OPPOSITION- Dyrvig et al, Medicine (2017) 96 (16). 1-7-
OPPOSITION- English translation of the Statement ot Opposition-
OPPOSITION- FANG, M. et al., "Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis.", Cancer, vol. 117, no. 10, doi:10.1002/cncr.25770, (20101129), pages 2024 - 34-
OPPOSITION- LI, X. et al., "Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.", Cancer Prev Res, (20080000), vol. 1, no. 6, pages 413 - 423117-
OPPOSITION- LORD, C.J. et al., "The DNA damage response and cancer therapy.", Nature, (20120119), vol. 481, no. 7381, doi:10.1038/nature10760, pages 287 - 94-
OPPOSITION- PFEIFER, D. et al., "Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays", Blood, vol. 109, no. 3, doi:10.1182/blood-2006-07-034256, (20061019), pages 1202 - 1210-
OPPOSITION- SMIDA, J. et al., "Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma.", Clin Cancer Res, vol. 16, no. 6, (20100707), pages 4256 - 4267-
OPPOSITION- Supplementary Material of D15-
OPPOSITION- Telli et al., Journal of Clinical Oncology (2015) 33 (17). 1895-901-
OPPOSITION- FANG, M. et al., "Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis.", Cancer, vol. 117, no. 10, doi:10.1002/cncr.25770, (20101129), pages 2024 - 34, XP002741861
OPPOSITION- LORD, C.J. et al., "The DNA damage response and cancer therapy.", Nature, (20120119), vol. 481, no. 7381, doi:10.1038/nature10760, pages 287 - 94, XP055174084
OPPOSITION- SMIDA, J. et al., "Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma.", Clin Cancer Res, vol. 16, no. 6, (20100707), pages 4256 - 4267, XP055030507
OPPOSITION- LI, X. et al., "Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.", Cancer Prev Res, (20080000), vol. 1, no. 6, pages 413 - 423117, XP055780585
OPPOSITION- PFEIFER, D. et al., "Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays", Blood, vol. 109, no. 3, doi:10.1182/blood-2006-07-034256, (20061019), pages 1202 - 1210, XP055085782
SEARCH- FANG MIN ET AL, "Genomic Differences Between Estrogen Receptor (ER)-Positive and ER-Negative Human Breast Carcinoma Identified by Single Nucleotide Polymorphism Array Comparative Genome Hybridization Analysis", CANCER, (201105), vol. 117, no. 10, pages 2024 - 2034, XP002741861 [X] 1 * the whole document *
SEARCH- GORRINGE K L ET AL, "Are there any more ovarian tumor suppressor genes ? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis", GENES CHROMOSOMES & CANCER, JOHN WILEY & SONS, INC, US, vol. 48, no. 10, doi:10.1002/GCC.20694, ISSN 1045-2257, (20091001), pages 931 - 942, (20090714), XP002703162 [A] 1-14 * the whole document *
SEARCH- KARIN LEUNEN ET AL, "Recurrent copy number alterations in BRCA1 -mutated ovarian tumors alter biological pathways", HUMAN MUTATION, (20091201), vol. 30, no. 12, doi:10.1002/humu.21135, ISSN 1059-7794, pages 1693 - 1702, XP055040581 [X] 1 * the whole document *
SEARCH- ARGOS M ET AL, "Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays", CANCER GENETICS AND CYTOGENETICS, ELSEVIER SCIENCE PUBLISHING, NEW YORK, NY, US, vol. 182, no. 2, doi:10.1016/J.CANCERGENCYTO.2008.01.001, ISSN 0165-4608, (20080415), pages 69 - 74, (20080411), XP022606023 [X] 1 * the whole document *
SEARCH- HENDRICKS C A ET AL, "''Recombomice'': The past, present, and future of recombination-detection in mice", DNA REPAIR, ELSEVIER, AMSTERDAM, NL, (20041005), vol. 3, no. 10, doi:10.1016/J.DNAREP.2004.04.006, ISSN 1568-7864, pages 1255 - 1261, XP004545307 [T] * the whole document *
SEARCH- MAECK LIENHARD ET AL, "Genetic instability in myelodysplastic syndrome: Detection of microsatellite instability and loss of heterozygosity in bone marrow samples with karyotype alterations", BRITISH JOURNAL OF HAEMATOLOGY, (200006), vol. 109, no. 4, ISSN 0007-1048, pages 842 - 846, XP002741862
SEARCH- S. L. VOLCHENBOUM ET AL, "Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis", CANCER RESEARCH, (20090512), vol. 69, no. 10, doi:10.1158/0008-5472.CAN-08-3112, ISSN 0008-5472, pages 4143 - 4149, XP055200253 [X] 1 * the whole document *
SEARCH- LIN L-J ET AL, "Integrated analysis of copy number alterations and loss of heterozygosity in human pancreatic cancer using a high-resolution, single nucleotide polymorphism array", ONCOLOGY (BASEL),, (20080901), vol. 75, no. 1-2, doi:10.1159/000155813, pages 102 - 112, XP008111449 [X] 1 * the whole document *
SEARCH- L. KUJAWSKI ET AL, "Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia", BLOOD, (20080901), vol. 112, no. 5, doi:10.1182/blood-2007-07-099432, ISSN 0006-4971, pages 1993 - 2003, XP055085975 [X] 1 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents